tiprankstipranks
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market

Taysha Gene Therapies (TSHA) Ownership - Who Owns Taysha Gene Therapies?

816 Followers

Taysha Gene Therapies (TSHA) Ownership Overview

20.48%12.01%55.83%11.68%
20.48% Insiders
55.83% Other Institutional Investors
11.68% Public Companies and Individual Investors
The ownership structure of Taysha Gene Therapies (TSHA) stock is a mix of institutional, retail and individual investors. Approximately 67.84% of the company’s stock is owned by Institutional Investors, 20.48% is owned by Insiders and 11.68% is owned by Public Companies and Individual Investors.
The ownership structure of Taysha Gene Therapies (TSHA) stock is a mix of institutional, retail and individual investors. Approximately 67.84% of the company’s stock is owned by Institutional Investors, 20.48% is owned by Insiders and 11.68% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 01, 2024
Paul B Manning
>10% Owner
Bought$2999999
Nov 20, 2023
Paul B Manning
>10% Owner
Bought$163000
Aug 16, 2023
Paul B Manning
>10% Owner
Bought$14820000
Aug 16, 2023Bought$100000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024Sold$352737
Mar 31, 2024Sold$31204083

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,992,802Institution5.46%22,755,100
10,872,503Institution5.40%22,506,081
7,472,060Institution3.71%15,467,164
7,075,643Institution3.51%14,646,581
6,021,535Institution2.99%12,464,577
5,690,075Institution2.83%11,778,455
5,679,180Institution2.82%11,755,903
4,004,756Institution1.99%8,289,845
818,309Institution0.41%1,693,900
326,276Institution0.16%675,392

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
10,992,802Institution5.46%22,755,100
6,021,535Institution2.99%12,464,577
5,690,075Institution2.83%11,778,455
818,309Institution0.41%1,693,900
243,880Institution0.12%504,832
150,700Institution0.07%311,949
102,518Institution0.05%212,212
88,081Institution0.04%182,328
26,474Institution0.01%54,801
21,044Institution0.01%43,561

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,026,826Institution2.00%13,812,013
3,835,823Institution1.90%8,247,019
2,469,279Institution1.23%5,308,950
2,469,279Institution1.23%5,308,950
2,469,279Institution1.23%5,308,950
1,439,752Institution0.71%4,938,349
1,415,059Institution0.70%3,042,377
1,034,871Institution0.51%2,224,973
349,749Institution0.17%751,960
314,039Institution0.16%675,184

FAQ

Who Owns Taysha Gene Therapies (TSHA)?
According to the latest TipRanks data, approximately 55.83% of the company's stock is held by institutional investors, 20.48% is held by insiders, and 11.68% is held by retail investors.
    What percentage of Taysha Gene Therapies (TSHA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 55.83% of Taysha Gene Therapies (TSHA) stock is held by institutional investors.
      What percentage of Taysha Gene Therapies (TSHA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 11.68% of Taysha Gene Therapies (TSHA) stock is held by retail investors.
        Who owns the most shares of Taysha Gene Therapies (TSHA)?
        Fidelity Select Portfolios owns the most shares of Taysha Gene Therapies (TSHA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis